After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Repare Therapeutics Inc is $58.66M. A total of 1.31 million shares were traded on the day, compared to an average of 370.39K shares.
In the most recent transaction, Segal Lloyd Mitchell sold 2,650 shares of RPTX for 4.62 per share on Mar 28 ’24. After the transaction, the PRESIDENT AND CEO now owns 110,049 company shares. In a previous transaction on Apr 01 ’24, Segal Lloyd Mitchell sold 2,491 shares at 4.63 per share. RPTX shares that PRESIDENT AND CEO owns now total 107,558.
Among the insiders who sold shares, Forte Steve disposed of 825 shares on Mar 28 ’24 at a per-share price of $4.62. This resulted in the EVP, CHIEF FINANCIAL OFFICER holding 45,564 shares of RPTX after the transaction. In another insider transaction, Forte Steve sold 789 shares at $4.61 per share on Apr 01 ’24. Company shares held by the EVP, CHIEF FINANCIAL OFFICER now total 44,775.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, RPTX has a high of $8.49 and a low of $1.20.
As of this writing, RPTX has an earnings estimate of -$0.79 per share for the current quarter. EPS was calculated based on a consensus of 3.0 estimates, with a high estimate of -$0.74 per share and a lower estimate of -$0.89.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. RPTX’s latest balance sheet shows that the firm has $341.87M in Cash & Short Term Investments as of fiscal 2021. There were $7.31M in debt and $35.09M in liabilities at the time. Its Book Value Per Share was $4.12, while its Total Shareholder’s Equity was $288.42M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RPTX is Buy with a score of 4.43.
